New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

Ambient data in clinical trials: the future of patient-reported outcomes

Collecting patient data through electronic PROs (ePROs) or electronic clinical outcome assessments (eCOAs) has been integral for patient centricity. These tools allow sponsors to meet patients where they are to gather real-time insights directly from the source, boosting patient retention and engagement. ePROs and eCOAs improve clinical trial outcomes with additional data points around a patient’s experience. However, the addition of consumer technologies that can collect ambient data points is poised to enhance outcomes even more, bringing treatments faster to those who need them most.

2

Biopharmaceutical mega M&A deals surge by 71% YoY during Q1 2024

Mergers and acquisitions (M&As) in the biopharmaceutical industry have rebounded with a $76.9 billion increase in total deal value seen from 2022 to 2023. In Q1 2024 alone, biopharmaceutical M&A reached a total deal value of $43.5 billion, with a 71% year-on-year (YoY) increase of mega deals that were valued at $1 billion or more compared to Q1 2023, reveals GlobalData.